AAAAAA

   
Results: 1-8 |
Results: 8
A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line
Authors: Supino, R Perego, P Gatti, L Caserini, C Leonetti, C Colantuono, M Zuco, V Carenini, N Zupi, G Zunino, F
Citation: R. Supino et al., A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line, EUR J CANC, 37(17), 2001, pp. 2247-2256
Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line
Authors: Leonetti, C Biroccio, A Benassi, B Stringaro, A Stoppacciaro, A Semple, SC Zupi, G
Citation: C. Leonetti et al., Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line, CANC GENE T, 8(6), 2001, pp. 459-468
Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity
Authors: Del Bufalo, D Trisciuoglio, D Biroccio, A Marcocci, L Buglioni, S Candiloro, A Scarsella, M Leonetti, C Zupi, G
Citation: D. Del Bufalo et al., Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity, J CELL BIOC, 83(3), 2001, pp. 473-483
In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors
Authors: Giorgi, M Leonetti, C Citro, G Augusti-Tocco, G
Citation: M. Giorgi et al., In vitro and in vivo inhibition of SK-N-MC neuroblastoma growth using cyclic nucleotide phosphodiesterase inhibitors, J NEURO-ONC, 51(1), 2001, pp. 25-31
Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts
Authors: Fiumicino, S Martinelli, S Colussi, C Aquilina, G Leonetti, C Crescenzi, M Bignami, M
Citation: S. Fiumicino et al., Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts, INT J CANC, 85(4), 2000, pp. 590-596
Increased TGF beta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells
Authors: Turco, A Scarpa, S Coppa, A Baccheschi, G Palumbo, C Leonetti, C Zupi, G Colletta, G
Citation: A. Turco et al., Increased TGF beta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells, EXP CELL RE, 255(1), 2000, pp. 77-85
Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide
Authors: Putney, SD Brown, J Cucco, C Lee, R Skorski, T Leonetti, C Geiser, T Calabretta, B Zupi, G Zon, G
Citation: Sd. Putney et al., Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide, ANTISENSE N, 9(5), 1999, pp. 451-458
Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotidesin a human metastatic melanoma inherently resistant to cisplatin
Authors: Leonetti, C Biroccio, A Candiloro, A Citro, G Fornari, C Mottolese, M Del Bufalo, D Zupi, G
Citation: C. Leonetti et al., Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotidesin a human metastatic melanoma inherently resistant to cisplatin, CLIN CANC R, 5(9), 1999, pp. 2588-2595
Risultati: 1-8 |